These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11818361)

  • 21. Zinc inhibits Bax and Bak activation and cytochrome c release induced by chemical inducers of apoptosis but not by death-receptor-initiated pathways.
    Ganju N; Eastman A
    Cell Death Differ; 2003 Jun; 10(6):652-61. PubMed ID: 12761574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
    Murphy KM; Streips UN; Lock RB
    Oncogene; 1999 Oct; 18(44):5991-9. PubMed ID: 10557088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
    Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
    Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common pathway for chemotherapy-induced apoptosis in human squamous cell carcinoma lines distinct from that of receptor-mediated cell death.
    Crowe DL; Yoon E
    Anticancer Res; 2003; 23(3B):2321-8. PubMed ID: 12894510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L; Yuan J; Stein R
    Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions.
    Levy-Strumpf N; Kimchi A
    Oncogene; 1998 Dec; 17(25):3331-40. PubMed ID: 9916995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis: target for novel drugs.
    Alam JJ
    Trends Biotechnol; 2003 Nov; 21(11):479-83. PubMed ID: 14573360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences at cellular level: "cells have a sex".
    Straface E; Gambardella L; Brandani M; Malorni W
    Handb Exp Pharmacol; 2012; (214):49-65. PubMed ID: 23027445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibition.
    Guttenplan N; Lee C; Frishman WH
    Heart Dis; 2001; 3(5):313-8. PubMed ID: 11975812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of apoptotic cell death in cardiovascular disease.
    McLaughlin R; Kelly CJ; Kay E; Bouchier-Hayes D
    Ir J Med Sci; 2001; 170(2):132-40. PubMed ID: 11491050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ins and outs of apoptosis in cardiovascular diseases.
    Russo GL; Russo M
    Nutr Metab Cardiovasc Dis; 2003 Oct; 13(5):291-300. PubMed ID: 14717062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-apoptotic serpins as therapeutics in cardiovascular diseases.
    Kuiper J; Quax PH; Bot I
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):111-22. PubMed ID: 23987999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of cell death in the cardiovascular system.
    Patel P; Karch J
    Int Rev Cell Mol Biol; 2020; 353():153-209. PubMed ID: 32381175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms and inhibitors of apoptosis in cardiovascular diseases.
    Singh SS; Kang PM
    Curr Pharm Des; 2011; 17(18):1783-93. PubMed ID: 21631422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis and cell death (mechanisms, pharmacology and promise for the future).
    Franko J; Pomfy M; Prosbová T
    Acta Medica (Hradec Kralove); 2000; 43(2):63-8. PubMed ID: 10953379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Apoptosis in cardiovascular diseases].
    Díez J
    Rev Esp Cardiol; 2000 Feb; 53(2):267-74. PubMed ID: 10734757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future perspectives and potential implications of cardiac myocyte apoptosis.
    Haunstetter A; Izumo S
    Cardiovasc Res; 2000 Feb; 45(3):795-801. PubMed ID: 10728403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Death by design. Programmed cell death in cardiovascular biology and disease.
    MacLellan WR; Schneider MD
    Circ Res; 1997 Aug; 81(2):137-44. PubMed ID: 9242174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research advances on preventive and therapeutic effects of hydrogen on cardiovascular and cerebrovascular diseases and underlying mechanisms].
    Xue JL; Song GH; Qin SC
    Sheng Li Xue Bao; 2018 Oct; 70(5):557-564. PubMed ID: 30377695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.